NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India Cements Sees Significant EBITDA Beat in 4QFY26

India Cements (ICEM) has reported a notable earnings beat in the fourth quarter of financial year 2026 (4QFY26). The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stood at INR1.6 billion, a significant improvement of 37% over the same period in the previous financial year (4QFY25), when it was INR11 million.

The strong EBITDA beat was driven by the company's all-round operating strength, leading to a substantial increase in EBITDA per ton (EBITDA/t) to INR498, a 62% quarter-on-quarter (QoQ) improvement. This growth was also reflected in the company's operating profit margin (OPM), which improved by 5.5 percentage points (pp) QoQ to approximately 13%.

In terms of net profit after tax (PAT), India Cements reported INR700 million in 4QFY26, a significant improvement over the estimated INR193 million and a reversal of the loss of INR618 million in 4QFY25.

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

Valuation and Outlook

Despite the encouraging results, Motilal Oswal's research report cautions that the current valuation of India Cements at 16 times its estimated earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) for financial year 2028 (FY28E) already reflects most of the operational improvements expected due to the company's transition. As a result, the research team does not see any further scope for re-rating the stock. Based on its valuation of 14 times FY28E EV/EBITDA, Motilal Oswal has set a target price (TP) of INR350 for India Cements and has reiterated a "Sell" recommendation.

Valuation MultipleEstimated FY28E EV/EBITDACurrent PriceTarget Price
16x
14xINR350INR350

Note: The table above compares the estimated EV/EBITDA valuation multiples for India Cements.

Read also: MarketSmith India's 4 June Stock Recommendations

Investor Takeaway

Investors should consider selling India Cements due to its current valuation.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.